ENT_Devices_Global Market Report_2018

ENT Devices Global Market
Report 2018
Including: Hearing Aid Devices; Hearing Diagnostic Devices; ENT Surgical Devices; Nasal Splints; Hearing
Implants; Voice Prosthesis Devices
Covering: Sonova Holdings AG, William Demant Holdings A/S, Medtronic plc, KARLSTORZ GmbH & Co.,
Stryker Corporation
Feb 2018

Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics
information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the
drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high
quality data and analysis
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 3-5
working days of order.
Scope
Markets Covered: Hearing Aid Devices; Hearing Diagnostic Devices; ENT Surgical Devices;
Nasal Splints; Hearing Implants; Voice Prosthesis Devices
Companies Mentioned: Sonova Holdings AG, William Demant Holdings A/S, Medtronic
plc, KARLSTORZ GmbH & Co., Stryker Corporation
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and
Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East And Africa.
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita,
ENT Devices Indicators Comparison.
Data segmentations: Country and regional historic and forecast data, market share of
competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end
notes.

ENT Devices Market
Characteristics
ENT devices are used for diagnosis, surgery and treatment of any kind of diseases
related to ear, nose and throat and thereby correct the problems related to
hearing, snoring, smelling or speaking. Diseases can include hear loss, chronic ear
disease, airway stenosis, airway tumors, cancer, feeding and swallowing
disorders, mastoiditis, voice disorders (Dysphonia), sinusitis and others. Some of
the popular ENT devices available in the market are endoscopes, hearing aids,
hearing implants, handheld surgical instruments, balloon sinus dilation devices,
CO2 lasers, image-guided surgery systems, ear tubes, and voice prosthesis
devices.
ENT devices market is classified into following segments
Hearing Screening Devices are designed to
ENT Surgical Equipment include devices used in
Hearing Aids are devices designed and developed to
Hearing Implants are surgically installed devices aimed to
Cochlear Implants are designed to
Bone Anchored Hearing System or Bone Anchored Hearing Aid (BAHA) are
surgically implanted devices used to
Mid-Ear Implants are surgically implanted into
Auditory Brainstem Implant (ABI) are surgically implanted devices that
Voice Prosthesis Devices are artificial devices provide the capability to
Nasal Splints are devices meant specifically to fit into or

In this report market value is defined as the revenues organizations earn by selling
their goods and services within the specified market, based on the price at which
they sell. Only goods and services traded between entities are included.
The revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

ENT Devices Market Historic
Growth
The global ENT devices market grew from $X billion in 2013 to $X billion in 2017 at
a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global ENT devices
market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:

ENT Devices Market Forecast
Growth
The global ENT devices market is expected to grow from $XX billion in 2017 to $11
billion in 2021 at a compound annual growth rate (CAGR) of XX%.
The chart and table below shows the year-on-year growth of the global ENT devices
market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:

ENT Devices Market
Segmentation
The chart and table below shows the split of the ENT devices market in 2017.
The total market value for ENT devices was $X billion in 2017. The markets that are
covered include Hearing Aid Devices; Hearing Diagnostic Devices; ENT Surgical
Devices; Nasal Splints; Hearing Implants; Voice Prosthesis Devices.
Hearing Aid Devices was the X largest segment in the ENT devices market with X%
share of the market. The market value for the hearing aid devices was $X billion in
2017.
Hearing Diagnostic Devices made up around X% share of the market. The market
value for the hearing diagnostic devices was $X billion in 2017.

ENT Devices Market Regional
And Country Analysis
The Asia Pacific was the largest region in the ENT devices market in 2017, ENT
devices for $X billion or X% market share.
North America was the x largest region ENT devices for $X billion or X% market
share.
Western Europe was the x largest region ENT devices for $X billion or X% market
share.

ENT Devices Market
Competitive Landscape
The leading competitors in the global ENT devices market are Sonova Holdings AG,
William Demant Holdings A/S, Medtronic plc, KARLSTORZ GmbH & Co., Stryker
Corporation.
The chart and table below displays the percentage market share of the top players
in the ENT devices market industry.
Sonova Holdings AG generated revenues of $XX billion for the financial year 2016,
a XX% increase from the previous year.
William Demant Holdings A/S generated revenues of $XX billion for the financial
year 2016, a XX% increase from the previous year.
Medtronic plc generated revenues of $XX billion for the financial year 2016, a XX%
increase from the previous year.
KARLSTORZ GmbH & Co generated revenues of $XX billion for the financial year
2016, a XX% increase from the previous year.

Stryker Corporation generated revenues of $XX billion for the financial year 2016,
a XX% increase from the previous year.
Smith & Nephew plc generated revenues of $XX billion for the financial year 2016,
a XX% increase from the previous year.
Cochlear Limited generated revenues of $XX billion for the financial year 2016, a
XX% increase from the previous year.
Acclarent Inc. generated revenues of $XX billion for the financial year 2016, an
XX% increase from the previous year.
Company Profile
Sonova Holdings AG
Overview
Sonova Holdings AG was the largest company in the ENT devices market with
a XX% share of the market in 2017.The Switzerland based company,
designs and manufactures hearing instruments, cochlear implants and
wireless communication solutions. It operates in 90 countries across the
globe through its brands such as Phonak, Unitron, Hansaton, Advanced
Bionics and AudioNova.
Products and Services
Sonova operates through two main product divisions –
The Hearing Instruments division provides products through its
The Cochlear Implants division is a surgically implanted electronic device
that
Strategy
Sonova’s growth strategy aims at acquiring competitors and hearing aid
retail stores across Europe. It has acquired Europe’s 2nd largest hearing aid
retailer, AudioNova for $954 million,

Financial Performance
Sonova Holding AG’s Hearing Instruments and Cochlear implants division
involved in the ENT devices manufacturing, generated revenues of CHF XX
billion ($XX billion) for the financial year 2016, a XX% increase from the
previous year. The company had a market
William Demant Holdings A/S
Overview
Products and Services
Strategy
Financial Performance
Medtronic plc
Overview
Products and Services
Strategy
Financial Performance
KARLSTORZ GmbH & Co.
Overview
Products and Services
Strategy
Financial Performance
Stryker Corporation
Overview
Products and Services
Strategy
Financial Performance